Skip to Main Content

Paper Details

Successful use of rituximab for hydralazine-induced anti-neutrophil cytoplasmic antibodies-associated vasculitis.
Saudi J Kidney Dis Transpl
7
2019
DAH, Hydralazine, RPGN, acute kidney injury, anti, anti-, anti-hypertensive, anti-neutrophil cytoplasmic antibodies, autoimmunity, diffuse alveolar hemorrhage, drug, glomerulonephritis, hydralazine, hypertension, patient, patients, rituximab, vasculitis
Author NameAffiliation
Joseph P GautWashington University School of Medicine
Anitha VijayanWashington University School of Medicine
  • 1 - 2

Datasets

Release 1.2